Human PTGES/MGST-IV/MGST1-L1 ORF/cDNA clone-Lentivirus plasmid (NM_004878)
Cat. No.: pGMLP000341
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human PTGES/MGST-IV/MGST1-L1 Lentiviral expression plasmid for PTGES lentivirus packaging, PTGES lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
PTGES/MGST-IV products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000341 |
| Gene Name | PTGES |
| Accession Number | NM_004878 |
| Gene ID | 9536 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 459 bp |
| Gene Alias | MGST-IV,MGST1-L1,MGST1L1,MPGES,mPGES-1,PGES,PIG12,PP102,PP1294,TP53I12 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCCTGCCCACAGCCTGGTGATGAGCAGCCCGGCCCTCCCGGCCTTCCTGCTCTGCAGCACGCTGCTGGTCATCAAGATGTACGTGGTGGCCATCATCACGGGCCAAGTGAGGCTGCGGAAGAAGGCCTTTGCCAACCCCGAGGATGCCCTGAGACACGGAGGCCCCCAGTATTGCAGGAGCGACCCCGACGTGGAACGCTGCCTCAGGGCCCACCGGAACGACATGGAGACCATCTACCCCTTCCTTTTCCTGGGCTTCGTCTACTCCTTTCTGGGTCCTAACCCTTTTGTCGCCTGGATGCACTTCCTGGTCTTCCTCGTGGGCCGTGTGGCACACACCGTGGCCTACCTGGGGAAGCTGCGGGCACCCATCCGCTCCGTGACCTACACCCTGGCCCAGCTCCCCTGCGCCTCCATGGCTCTGCAGATCCTCTGGGAAGCGGCCCGCCACCTGTGA |
| ORF Protein Sequence | MPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-IP0039-Ab | Anti-PTGES monoclonal antibody |
| Target Antigen | GM-Tg-g-IP0039-Ag | PTGES protein |
| ORF Viral Vector | pGMLP000341 | Human PTGES Lentivirus plasmid |
| ORF Viral Vector | pGMPC001111 | Human PTGES Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP000341 | Human PTGES Lentivirus particle |
Target information
| Target ID | GM-IP0039 |
| Target Name | PTGES |
|
Gene Group Identifier (Target Gene ID in Homo species) |
9536 |
| Gene ID |
100034143 (Equus caballus), 101086187 (Felis catus), 282019 (Bos taurus), 480698 (Canis lupus familiaris) 59103 (Rattus norvegicus), 64292 (Mus musculus), 716657 (Macaca mulatta), 9536 (Homo sapiens) |
| Gene Symbols & Synonyms | PTGES,Ptges,MPGES-1,PGES,Pges,mPGES-1,mPGES,D2Ertd369e,2410099E23Rik,MPGES,PIG12,PP102,PP1294,MGST-IV,MGST1L1,TP53I12,MGST1-L1 |
| Target Alternative Names | 2410099E23Rik,D2Ertd369e,Glutathione peroxidase PTGES,Glutathione transferase PTGES,MGST-IV,MGST1-L1,MGST1L1,MPGES,MPGES-1,Microsomal glutathione S-transferase 1-like 1 (MGST1-L1),Microsomal prostaglandin E synthase 1 (MPGES-1),PGES,PIG12,PP102,PP1294,PTGES,Pges,Prostaglandin E synthase,Ptges,TP53I12,mPGES,mPGES-1,p53-induced gene 12 protein |
| Uniprot Accession |
A0SYQ0,O14684,Q8HZJ2,Q95L14,Q9JHF3,Q9JM51
Additional SwissProt Accessions: Q8HZJ2,Q95L14,A0SYQ0,Q9JHF3,Q9JM51,O14684 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | Metabolic pathways, Arachidonic acid metabolism |
| Gene Ensembl | ENSECAG00000000943, ENSBTAG00000019453, ENSCAFG00845023377, ENSMUSG00000050737, ENSG00000148344 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


